RPG Life Sciences Ltd

Fri 7/08/2026,15:51:49 | NSE : RPGLIFE

₹2661.30-27.60 (-1.03%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 2660.10

Previous Close

₹ 2688.90

Volume

9022

Mkt Cap ( ₹ Cr)

₹ 4401.53

High

₹ 2709.90

Low

₹ 2645.80

52 Week High

₹ 3082.00

52 Week Low

₹ 1733.00

Book Value Per Share

₹ 366.03

Dividend Yield

0.90

Face Value

₹ 8.00

What's Your Call?

Collective community sentiment on RPG Life Sciences Ltd

Your Vote -

Buy

50.00%

Hold

10.00%

Sell

40.00%

50.00%

10 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

2661.30

1

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

1

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts RPG Life Sciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • RPG Life Sciences - Cessation

    31 Jul 2026, 11:22PM Intimation on Superannuation of Senior Management Personnel

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Change in Management

    31 Jul 2026, 11:22PM Intimation on superannuation of Senior Management Personnel

  • RPG Life Sciences - Copy of Newspaper Publication

    31 Jul 2026, 3:14PM Newspaper Advertisement in respect to Special Window opened for lodgment of transfer and dematerialization request(s).

  • RPG Life Sciences - Press Release

    29 Jul 2026, 11:52PM RPG Life Sciences Limited has informed the Exchange regarding a press release dated July 29, 2026, titled ""Press release"".

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    29 Jul 2026, 11:52PM Press Release

  • RPG Life Sciences - General Updates

    29 Jul 2026, 11:45PM Execution of Share Purchase Agreement

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Acquisition

    29 Jul 2026, 11:45PM Execution of Share Purchase Agreement

  • RPG Life Sciences - Other Restructuring

    29 Jul 2026, 11:41PM Execution of Business Transfer Agreement

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Restructuring

    29 Jul 2026, 11:41PM Execution of Business Transfer Agreement

  • RPG Life Sciences - Outcome Of Board Meeting Held Today July 29, 2026

    29 Jul 2026, 11:37PM Outcome of Board Meeting held today July 29, 2026

  • RPG Life Sciences - General Updates

    29 Jul 2026, 11:37PM Outcome of Board Meeting held today July 29, 2026

  • RPG Life Sciences - Copy of Newspaper Publication

    29 Jul 2026, 1:10PM Copy of Newspaper Publication

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation

    28 Jul 2026, 8:40PM Investor Presentation

  • RPG Life Sciences - Investor Presentation

    28 Jul 2026, 8:38PM RPG Life Sciences Limited has informed the Exchange about Investor Presentation

  • RPG Life Sciences - Press Release

    28 Jul 2026, 8:11PM Press Release

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    28 Jul 2026, 8:11PM Press release

  • RPG Life Sciences - Unaudited Financial Results For The Quarter Ended June 30, 2026

    28 Jul 2026, 8:04PM Unaudited consolidated and standalone Financial Results for quarter ended June 2026

  • RPG Life Sciences - Outcome of Board Meeting

    28 Jul 2026, 7:55PM Outcome of Board meeting

  • RPG Life Sciences - Board Meeting Outcome for Outcome Of Board Meeting

    28 Jul 2026, 7:54PM Outcome of Board meeting

  • RPG Life Sciences - Resignation of Director/KMP/SMP

    27 Jul 2026, 1:04PM RPG Life Sciences Limited has informed the Exchange about Resignation of Director/KMP/SMP

  • RPG Life Sciences - Resignation of Director/KMP/SMP

    27 Jul 2026, 1:02PM RPG Life Sciences Limited has informed the Exchange about Resignation of Director/KMP/SMP

  • RPG Life Sciences - Cessation

    27 Jul 2026, 12:03PM RPG Life Sciences Limited has informed the Exchange regarding Cessation of as Independent Director of the company w.e.f. July 26, 2026.

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Cessation

    27 Jul 2026, 12:04PM Completion of term of Ms. Zahabiya Khorakiwala

  • RPG Life Sciences - Shareholders meeting

    23 Jul 2026, 11:22PM Voting result along with Scrutinizer report

  • RPG Life Sciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Jul 2026, 11:02PM Voting Results along with a copy of Scrutinizer's Report

  • RPG Life Sciences - Shareholders meeting

    23 Jul 2026, 10:57PM 19th AGM Proceedings

  • RPG Life Sciences - Shareholder Meeting / Postal Ballot-Outcome of AGM

    23 Jul 2026, 10:56PM 19th AGM Proceedings

  • RPG Life Sciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Jul 2026, 11:02PM Voting Results along with a copy of Scrutinizer's Report

  • RPG Life Sciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Jul 2026, 11:02PM Voting Results along with a copy of Scrutinizer's Report

  • RPG Life Sciences - Board Meeting Intimation for Financial Result For Quarter Ended June 2026

    21 Jul 2026, 7:06PM RPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia, to consider an

  • RPG Life Sciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Jul 2026, 11:02PM Voting Results along with a copy of Scrutinizer's Report

  • RPG Life Sciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Jul 2026, 11:02PM Voting Results along with a copy of Scrutinizer's Report

  • RPG Life Sciences has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    20 Jul 2026, 3:50PM As of June 2026, 72.95% is owned by Indian Promoters and 27.05% by Public. <p align=justify> Institutional holds 9.63% (Insurance Companies 0.21%) and

  • RPG Life Sciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    13 Jul 2026, 8:27PM Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

  • RPG Life Sciences - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    13 Jul 2026, 8:27PM Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

  • RPG Life Sciences - Press Release

    13 Jul 2026, 12:37PM Press release with respect to Naprosyn ES Launch

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    13 Jul 2026, 12:37PM Press release with respect to Naprosyn ES Launch

  • RPG Life Sciences - Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The Company

    2 Jul 2026, 7:20PM Intimation under regulation 30 regarding letter dispatched to those Shareholders whose email addresses are not registered with Company/RTA/ NSDL / CDS

  • RPG Life Sciences - Copy of Newspaper Publication

    2 Jul 2026, 7:08PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the copy of Notice of 1

  • RPG Life Sciences - General Updates

    2 Jul 2026, 7:05PM Pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Company has sent a letter to those

  • RPG Life Sciences - Business Responsibility and Sustainability Reporting (BRSR)

    1 Jul 2026, 6:23PM Business Responsibility and Sustainability Report 2026

  • RPG Life Sciences - Shareholders meeting

    1 Jul 2026, 6:22PM Notice of 19th Annual General Meeting of the Company

  • RPG Life Sciences - Notice Of 19Th Annual General Meeting Of The Company

    1 Jul 2026, 6:19PM Notice of 19th Annual General Meeting

  • RPG Life Sciences - Reg. 34 (1) Annual Report.

    1 Jul 2026, 6:10PM Annual Report

  • RPG Life Sciences - Trading Window

    25 Jun 2026, 7:15PM RPG Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations

  • RPG Life Sciences has declared 300% Final dividend for the financial year March 2026

    25 Jun 2026, 7:30AM RPG Life Sciences Ltd. on Wednesday, 29 April 2026, has announced Final dividend of 300 percent on Equity Share, to its shareholders holding shares on

  • RPG Life Sciences - Copy of Newspaper Publication

    23 Jun 2026, 7:32PM Newspaper Publication

  • RPG Life Sciences - Record Date For Determining Members Eligible To Receive Dividend For The Financial Year 2025-26.

    22 Jun 2026, 6:46PM Record date for determining members eligible to receive dividend for the financial year 2025-26.

  • RPG Life Sciences - Record Date

    22 Jun 2026, 6:45PM RPG Life Sciences Limited has informed the Exchange that Record date for the purpose of Dividend is 09-Jul-2026.

  • RPG Life Sciences - Cancellation of Book closure

    16 Jun 2026, 12:32PM RPG Life Sciences Limited had intimated the 19-Jun-2026 for the purpose of DI. The Company now cancelled the said RecordDate

  • RPG Life Sciences - Clarification For Volume Movement Letter

    12 Jun 2026, 2:58PM Clarification for Volume Movement Letter

  • RPG Life Sciences - Clarification sought from RPG Life Sciences Ltd

    12 Jun 2026, 12:45PM The Exchange has sought clarification from RPG Life Sciences Ltd on June 12, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.

  • RPG Life Sciences - Spurt in Volume

    12 Jun 2026, 10:55AM Significant increase in volume has been observed in RPG Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant in

  • RPG Life Sciences - Spurt in Volume

    11 Jun 2026, 6:04PM Significant increase in volume has been observed in RPG Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant in

  • RPG Life Sciences - Communication To Shareholders - Intimation On Dividend Taxation Provisions

    9 Jun 2026, 7:15PM Communication to shareholders - Intimation on dividend Taxation provisions

  • RPG Life Sciences - General Updates

    9 Jun 2026, 7:14PM Communication to shareholders - Intimation on dividend Taxation provisions

  • RPG Life Sciences - Intimation To Shareholders Holding Shares In Physical Form For Furnishing KYC Details

    9 Jun 2026, 7:11PM Intimation to shareholders holding shares in physical form for furnishing KYC details

  • RPG Life Sciences - General Updates

    9 Jun 2026, 7:11PM Intimation to shareholders holding shares in physical form for furnishing KYC details

  • RPG Life Sciences - Disclosure under SEBI Takeover Regulations

    9 Jun 2026, 12:32PM ÿSwallowÿAssociatesÿLLPÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Subst

  • RPG Life Sciences - General Update

    3 Jun 2026, 7:20PM Intimation letter to shareholders regarding transfer of shares to IEPF and newspaper publication.

  • RPG Life Sciences - General Updates

    3 Jun 2026, 7:15PM Intimation letter to shareholders regarding transfer of shares to IEPF and newspaper publication

  • RPG Life Sciences - Investor Presentation

    25 May 2026, 8:53PM RPG Life Sciences Limited has informed the Exchange about Investor Presentation

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation

    25 May 2026, 8:48PM Investor Presentation

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 May 2026, 8:28AM Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    22 May 2026, 8:28AM RPG Life Sciences Limited has informed the Exchange about Schedule of meet

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    8 May 2026, 4:45PM The Company informed the Exchange about Transcript of Earnings Call.

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    8 May 2026, 4:45PM The Company has informed the Exchange about Transcript of Earnings Call.

  • RPG Life Sciences partners with Archerchem Healthcare for Naprosyn ES launch

    13 Jul 2026 , 1:45PM RPG Life Sciences partners with Archerchem Healthcare to launch Naproxen and Esomeprazole combination for the first time in India
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of RPG Life Sciences Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 625.37 530.53 374.85 307.61 256.06
Liabilities 625.37 530.53 374.85 307.61 256.06
Equity 13.23 13.23 13.23 13.23 13.23
Gross Profit 147.13 159.65 128.15 102.69 86.36
Net Profit 115.17 183.24 87.66 67.64 51.48
Cash From Operating Activities 56.5 77.86 94.36 90.82 64.75
NPM(%) 16.27 28.04 15.06 13.19 11.69
Revenue 707.52 653.43 582.05 512.81 440.16
Expenses 560.39 493.78 453.9 410.12 353.8
ROE(%) 19.02 30.26 14.48 11.17 8.5

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
09 Jul 2026 24 300 0.9 2030.5
27 Jun 2025 4 50 0.9 2091.3
27 Jun 2025 20 250 0.9 2174.5
28 Jun 2024 16 200 0.9 1546.4
14 Jul 2022 9.6 120 0.9 590.65
13 Aug 2021 7.2 90 0.9 485.1
24 Mar 2020 4 50 0.9 219.05
22 Jul 2019 2.4 30 0.9 234.7
19 Jul 2018 2.4 30 0.9 412.1
13 Jul 2017 2.8 35 0.9 440.15
22 Mar 2016 1.6 20 0.9 252.3
20 Jul 2015 0.8 10 0.9 140.15
11 Sep 2014 1.2 15 0.9 70.6
11 Jul 2013 1.2 15 0.9 61.55
24 Jul 2012 0.8 10 0.9 64
14 Jul 2011 1.6 20 0.9 80
15 Jul 2010 1.44 18 0.9 70.65
30 Jul 2009 1.2 15 0.9 31.35
11 Aug 2008 1.2 15 0.9 25.75

Peers

Other companies within the same industry or sector that are comparable to RPG Life Sciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 822.85 12.63 20.81 1517.17 -26.19 0.61
Lotus Eye Hospital and Institute Ltd 118.82 1.35 3960.67 5528.38 0.39 0.00
Vaishali Pharma Ltd 7.88 -1.25 26.27 34681.39 15.42 0.00
Astec Lifesciences Ltd 620.50 0.02 0.00 5923.36 -363.14 0.00

Company Info

2009 - Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009. 2010 - Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company. - Mr. Sachin Raole, General Manager Finance has been designated as Chief Financial Officer (CFO) of the Company. 2011 - RPG Life Sciences launches dialysis deferring drug. - Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company. 2012 -Board has recommended an equity dividend of Rs. 0.80 per share (10%). 2013 -RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility." -RPG Life Sciences bagged "Asia's Best Employer Brand Awards 2013" in Singapore. 2014 -Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014. 2015 -RPG Life Plans Skincare Foray 2016 -RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic Industry -RPG Life gains over 14 pct on getting EUGMP certification -RPG Life Sciences - RPG Life Sciences to expand its formulations business 2019 -RPG Life Sciences enters Anti-Diabetic therapeutic area.

2009 - Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009. 2010 - Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company. - Mr. Sachin Raole, General Manager Finance has been designated as Chief Financial Officer (CFO) of the Company. 2011 - RPG Life Sciences launches dialysis deferring drug. - Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company. 2012 -Board has recommended an equity dividend of Rs. 0.80 per share (10%). 2013 -RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility." -RPG Life Sciences bagged "Asia's Best Employer Brand Awards 2013" in Singapore. 2014 -Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014. 2015 -RPG Life Plans Skincare Foray 2016 -RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic Industry -RPG Life gains over 14 pct on getting EUGMP certification -RPG Life Sciences - RPG Life Sciences to expand its formulations business 2019 -RPG Life Sciences enters Anti-Diabetic therapeutic area.

Parent Organisation

RPG Life Sciences Ltd.

Founded

29/03/2007

Managing Director

Mr.Ashok Nair

NSE Symbol

RPGLIFEEQ

FAQ